American Portfolios Advisors Bluebird Bio, Inc. Transaction History
American Portfolios Advisors
- $2.36 Trillion
- Q3 2022
A detailed history of American Portfolios Advisors transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, American Portfolios Advisors holds 56 shares of BLUE stock, worth $266. This represents 0.0% of its overall portfolio holdings.
Number of Shares
56Holding current value
$266% of portfolio
0.0%Shares
13 transactions
Others Institutions Holding BLUE
# of Institutions
18Shares Held
20.2MCall Options Held
0Put Options Held
2K-
Black Rock Inc. New York, NY15.4MShares$73.5 Million0.0% of portfolio
-
Pictet Asset Management Sa Geneva 73, V84.67MShares$22.2 Million0.02% of portfolio
-
Colony Group LLC Boston, MA41.9KShares$199,6430.0% of portfolio
-
Connacht Asset Management LP New York, NY31.6KShares$150,5770.59% of portfolio
-
Raymond James Financial Services Advisors, Inc. St. Petersburg, FL28.7KShares$136,6590.0% of portfolio
About bluebird bio, Inc.
- Ticker BLUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,121,800
- Market Cap $367M
- Description
- bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...